KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Cash & Current Investments (2017 - 2025)

Historic Cash & Current Investments for Twist Bioscience (TWST) over the last 9 years, with Q4 2025 value amounting to $198.0 million.

  • Twist Bioscience's Cash & Current Investments fell 2689.06% to $198.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $198.0 million, marking a year-over-year decrease of 2689.06%. This contributed to the annual value of $232.4 million for FY2025, which is 1590.64% down from last year.
  • As of Q4 2025, Twist Bioscience's Cash & Current Investments stood at $198.0 million, which was down 2689.06% from $232.4 million recorded in Q3 2025.
  • Over the past 5 years, Twist Bioscience's Cash & Current Investments peaked at $573.9 million during Q1 2022, and registered a low of $198.0 million during Q4 2025.
  • In the last 5 years, Twist Bioscience's Cash & Current Investments had a median value of $323.8 million in 2023 and averaged $368.0 million.
  • The largest annual percentage gain for Twist Bioscience's Cash & Current Investments in the last 5 years was 14152.32% (2021), contrasted with its biggest fall of 4860.09% (2021).
  • Over the past 5 years, Twist Bioscience's Cash & Current Investments (Quarter) stood at $301.9 million in 2021, then skyrocketed by 45.34% to $438.7 million in 2022, then fell by 29.08% to $311.1 million in 2023, then dropped by 12.96% to $270.8 million in 2024, then decreased by 26.89% to $198.0 million in 2025.
  • Its Cash & Current Investments stands at $198.0 million for Q4 2025, versus $232.4 million for Q3 2025 and $250.8 million for Q2 2025.